BofA Securities analyst Allen Lutz maintains $McKesson (MCK.US)$ with a buy rating, and maintains the target price at $635.
According to TipRanks data, the analyst has a success rate of 55.0% and a total average return of 2.6% over the past year.
Furthermore, according to the comprehensive report, the opinions of $McKesson (MCK.US)$'s main analysts recently are as follows:
McKesson's solid performance has effectively challenged the bearish long-term projections concerning target risks, as evidenced by a 5% increase in shares.
The firm noted that McKesson's strong results were evident across all segments, with the F2Q performance in US Pharma being particularly robust. Additionally, the implication of segment EBIT acceleration in FY25, as suggested by the midpoint of the guidance, is seen as encouraging.
McKesson has resolved several concerns and eliminated some significant issues. The company, along with its peers, has consistently reported strong updates. The large-cap healthcare sector is seen as comparatively less saturated with investors and relatively undervalued. It is suggested that there is no compelling reason why the company should not move back towards its recently higher valuation multiples.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美銀證券分析師Allen Lutz維持$麥克森 (MCK.US)$買入評級，維持目標價635美元。
根據TipRanks數據顯示，該分析師近一年總勝率為55.0%，總平均回報率為2.6%。
此外，綜合報道，$麥克森 (MCK.US)$近期主要分析師觀點如下：
麥克森的穩健表現有效地挑戰了看淡的長期風險預測，股價增長5%也爲此提供了證據。
該公司指出麥克森強勁的業績在所有板塊均有體現，尤其是美國醫藥的F2Q表現尤爲強勁。此外，根據指引中點所示的FY25段營業利潤加速的暗示被視爲積極的。
麥克森解決了幾個問題並消除了一些重要事項。與同行公司一樣，該公司一直在穩健的業績報告中一直擁有堅實的更新。大市值醫療保健板塊被視爲相對較少被投資者涵蓋且相對被低估的板塊。建議公司沒有什麼理由不恢復至最近更高的估值倍數。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
